p-Azidophenylarsenoxide: An Arsenical “Bait” for the In Situ Capture and Identification of Cellular Arsenic-Binding Proteins-Reference-Cited by-同舟云学术

p-Azidophenylarsenoxide: An Arsenical “Bait” for the In Situ Capture and Identification of Cellular Arsenic-Binding Proteins

Published:2016-10-10 Issue:45 Volume:55 Page:14051-14056
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Yan Xiaowen¹,Li Jinhua¹,Liu Qingqing¹,Peng Hanyong¹,Popowich Aleksandra²,Wang Zhixin¹,Li Xing-Fang¹^ORCID,Le X. Chris¹²^ORCID

Affiliation:

1. Division of Analytical and Environmental Toxicology; Department of Laboratory Medicine and Pathology; University of Alberta; Edmonton Alberta T6G2G3 Canada

2. Department of Chemistry; University of Alberta; Edmonton Alberta T6G2G2 Canada

Publisher

Wiley

Subject

General Chemistry,Catalysis

Reference69 articles.

1. The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem

2. Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

3. The role of protein binding of trivalent arsenicals in arsenic carcinogenesis and toxicity

4. Arsenic Binding to Proteins

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Customizable Zr-MOF nanoantidote-based multieffective arsenic detoxification and its extended low-toxic therapy;Acta Biomaterialia;2024-07

2. Histidine tag modified magnetic beads for analysis of arsenic binding proteins;Analytica Chimica Acta;2024-05

3. Identification of Cellular Protein Targets of a Half-Sandwich Iridium(III) Complex Reveals Its Dual Mechanism of Action via Both Electrophilic and Oxidative Stresses;Journal of Medicinal Chemistry;2024-04-05

4. Reinvent Aliphatic Arsenicals as Reversible Covalent Warheads toward Targeted Kinase Inhibition and Non-acute Promyelocytic Leukemia Cancer Treatment;Journal of Medicinal Chemistry;2024-04-01

5. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model;Chemical Science;2024